ClinicalTrials.gg
CompletedNCT01915368Updated Dec 16, 2019

Determining Optimal Post-Stroke Exercise (DOSE)

An interventional study of Stroke Management Program (SMP) and Stroke Monitoring Program (SMonP) in Cerebrovascular Accident, Stroke and Cerebral Infarction, sponsored by University of British Columbia. Completed at 8 sites in Canada. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2019-12-16.

Primary conditionCerebral InfarctionRegistry: StrokeReclassifiedWhy we changed it
Registry
Stroke — the first condition term the registry derived for this study.
ClinicalTrials.gg
Cerebral Infarction
Why
  1. The study's listed conditions name Cerebral Infarction, a narrower term within Stroke.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of British Columbia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Study summary

The investigators will conduct a proof-of-concept study to provide preliminary evidence of efficacy of physical exercise dose on ambulatory function in adults undergoing sub-acute stroke rehabilitation.

Read the detailed description

Participants admitted for stroke rehabilitation will be randomly assigned to either the Stroke Management Group, Stroke Monitoring Group or Stroke Supplementary Group. All three groups will receive usual care, in addition to the intervention. The Stroke Management Group will be provided with periodic information about their progress in the area of mobility using specialized activity monitors. The Stroke Monitoring Group will be progressed according to customized protocols using feedback from specialized activity monitors. The Stroke Supplementary Group will receive the same as the Stroke Monitoring Group, but will also receive one additional hour of daily (5 times per week) physical exercise

02

Conditions studied

  • Cerebrovascular Accident
  • Stroke
  • Cerebral Infarction
  • Brain Infarction
  • Brain Ischemia
  • Cerebrovascular Disorders
  • Brain Diseases
  • Central Nervous System Diseases
  • Nervous System Diseases
  • Vascular Diseases

Keywords

  • Exercise
  • Rehabilitation
  • Dose
  • Randomized controlled trial
  • Stroke
03

In context

Cerebral Infarction Reclassified

219 studies on the registry are indexed under Cerebral Infarction; 46 are open to participants now.

This study's enrollment of 75 is below the median of 120 across 139 interventional studies indexed under Cerebral Infarction.

Browse Cerebral Infarction studies →

Lead sponsor

University of British Columbia is the lead sponsor of 1,339 studies on the registry; 259 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 1 (17%) have results posted.

Compared within Cerebral Infarction, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Stroke. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Have been admitted to a hospital unit for stroke rehabilitation
  • Within 10 weeks post-stroke
  • 19 years or older
  • Are experiencing difficulty walking

Exclusion criteria

Exclusion Criteria:

  • Requires greater than one person assist for transfer or ambulation
  • Have uncontrolled medical condition or another serious medication condition in addition to stroke
  • Unable to understand or follow directions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
75 participants (actual)

Study arms

  • Active comparator
    Stroke Management Program (SMP)

    Participants will have usual care, and in addition, be provided with periodic information about their progress in the area of mobility using specialized activity monitors

    Behavioral: Stroke Management Program (SMP)

  • Experimental
    Stroke Monitoring Program (SMonP)

    Participants will have usual care, and in addition, be progressed according to customized protocols using feedback from specialized activity monitors

    Behavioral: Stroke Monitoring Program (SMonP)

  • Experimental
    Stroke Supplementary Program (SSP)

    Participants will have usual care, and in addition, will receive the same as the Stroke Monitoring Group, and also receive one additional hour of daily (5 times per week) physical exercise

    Behavioral: Stroke Supplementary Program (SSP)

Interventions

  • BehavioralStroke Management Program (SMP)

    Participants will have usual care, and in addition, be provided with periodic information about their progress in the area of mobility using specialized activity monitors

  • BehavioralStroke Monitoring Program (SMonP)

    Participants will have usual care, and in addition, be progressed according to customized protocols using feedback from specialized activity monitors

  • BehavioralStroke Supplementary Program (SSP)

    Participants will have usual care, and in addition, will receive the same as the Stroke Monitoring Group, and also receive one additional hour of daily (5 times per week) physical exercise

06

What researchers measure

Primary outcomes

  1. Ambulatory function measured by the Six Minute Walk Test

    Time frame: Rehabilitation discharge (average 4-5 weeks post admission)

Secondary outcomes

  1. Ambulatory Function from the Six Minute Walk Test

    Time frame: 6 and 12 months post-stroke

  2. Ambulatory function from the 5 Meter Walk Test

    Time frame: Rehabilitation discharge (average 4-5 weeks post admission) , 6 and 12 months post-stroke

  3. Balance function from the Berg Balance Scale

    Time frame: Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke

  4. Ambulatory function from the Functional Ambulation Classification

    Time frame: Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke

  5. Quality of life measured with EuroQol

    Time frame: Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke

  6. Cognition measured by the Montreal Cognitive Assessment

    Time frame: Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke

  7. Cognition measured by the Digit Symbols Substitution Test

    Time frame: Rehabilitation discharge (average 4-5 weeks post admission) , 6 and 12 months post-stroke

  8. Cognition measured by the Trail Making Test

    Time frame: Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke

  9. Depression measured by Patient Health Questionnaire-9

    Time frame: Rehabilitation discharge (average 4-5 weeks post admission) , 6 and 12 months post-stroke

  10. Heart rate measured during the intervention sessions

    Time frame: From 10 intervention sessions within the 4-week intervention

  11. Step count measured during the intervention sessions

    Time frame: From 10 intervention sessions within the 4-week intervention

07

Study locations

8 sites
  • Fanning Centre
    Calgary, Alberta, Canada
  • Foothills Medical Centre
    Calgary, Alberta, Canada
  • Laurel Place
    Surrey, British Columbia V3T 4H9, Canada
  • Surrey Memorial Hospital
    Surrey, British Columbia V3V 1Z2, Canada
  • GF Strong Rehab Centre
    Vancouver, British Columbia V5Z 2G9, Canada
  • Holy Family Hospital
    Vancouver, British Columbia, Canada
  • Riverview Health Centre
    Winnipeg, Manitoba R3L 2P4, Canada
  • Toronto Rehabilitation Institute
    Toronto, Ontario, Canada
08

References and documents

Publications

  • Peters S, Klassen T, Schneeberg A, Dukelow S, Bayley M, Hill M, Pooyania S, Yao J, Eng J. Step Number and Aerobic Minute Exercise Prescription and Progression in Stroke: A Roadmap. Neurorehabil Neural Repair. 2022 Feb;36(2):97-102. doi: 10.1177/15459683211062894. Epub 2021 Dec 23. PubMed 34949129 ↗
  • Klassen TD, Dukelow SP, Bayley MT, Benavente O, Hill MD, Krassioukov A, Liu-Ambrose T, Pooyania S, Poulin MJ, Schneeberg A, Yao J, Eng JJ. Higher Doses Improve Walking Recovery During Stroke Inpatient Rehabilitation. Stroke. 2020 Sep;51(9):2639-2648. doi: 10.1161/STROKEAHA.120.029245. Epub 2020 Aug 19. PubMed 32811378 ↗
  • Janssen J, Klassen TD, Connell LA, Eng JJ. Factors Influencing the Delivery of Intensive Rehabilitation in Stroke: Patient Perceptions Versus Rehabilitation Therapist Perceptions. Phys Ther. 2020 Feb 7;100(2):307-316. doi: 10.1093/ptj/pzz159. PubMed 31711211 ↗
  • Klassen TD, Dukelow SP, Bayley MT, Benavente O, Hill MD, Krassioukov A, Liu-Ambrose T, Pooyania S, Poulin MJ, Yao J, Eng JJ. Determining optimal poststroke exercise: Study protocol for a randomized controlled trial investigating therapeutic intensity and dose on functional recovery during stroke inpatient rehabilitation. Int J Stroke. 2019 Jan;14(1):80-86. doi: 10.1177/1747493018785064. Epub 2018 Jul 16. PubMed 30010509 ↗
  • Klassen TD, Semrau JA, Dukelow SP, Bayley MT, Hill MD, Eng JJ. Consumer-Based Physical Activity Monitor as a Practical Way to Measure Walking Intensity During Inpatient Stroke Rehabilitation. Stroke. 2017 Sep;48(9):2614-2617. doi: 10.1161/STROKEAHA.117.018175. Epub 2017 Aug 7. PubMed 28784922 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 16, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01915368
Responsible party
Janice Eng (Principal Investigator, University of British Columbia) — Principal investigator
First posted
Aug 2, 2013
Start date
Sep 2013
Primary completion
Dec 2019
Completion
Dec 2019
Last update
Dec 16, 2019

Study contacts

Janice Eng, PhD
principal investigator · The University of British Columbia

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion